Published in Lab Business Week, January 21st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Lifeline Therapeutics.
Report 1: Lifeline Therapeutics, Inc., (LFLT), maker of Protandim, a patent-pending dietary supplement designed to increase the body's natural antioxidant defenses, announced the appointment of Larry Gold, PhD, to its board of directors.
Gold has served on the Lifeline Therapeutics scientific advisory board since February 2006 and will now serve in both positions.
Gold is the founder, CEO, chairman of the board, and chief...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week